News

Azur Pharma Announces the Closing of the Acquisition of PRIALT®

10th May 2010

Azur Pharma Announces Licensing of Clozapine Oral Suspension Product

8th April 2010

Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT® From Elan

11th March 2010

Azur Pharma Announces Commercialisation of Elestrin™

14th April 2009

Azur Pharma Announces the Licensing of Niravam®, Parcopa®, Kemstro™ and Fluxid™ From UCB

9th January 2009

Azur Pharma Announces the Acquisition of Elestrin™

04th December 2008

Azur Pharma and Elan Corporation Sign Agreement to Develop a Once-Daily Clozapine

10th November 2008

Azur Pharma and IntelGenx Corp. Enter License and Development Agreement for U.S. Prescription Prenatal Vitamins

7th January 2008

Azur Pharma Announces License and Supply Agreement with Martek Biosciences Corporation. Launch of New Prescription Prenatal Product for the United States

15th November 2007

Azur Pharma Completes Equity Financing for $48 Million. FazaClo Acquisition Completed.

7th August 2007

Azur Pharma Announces the Acquisition of FazaClo.

3rd July 2007

Azur Pharma Announces the Appointment of Mr. Anthony Tebbutt.

9th March 2007

Azur Pharma Announces the Acquisition of Pharmelle.

26th February 2007

Azur Pharma Announces the Appointment of Senior Vice President for Technical Operations.

26th September 2006

Azur Pharma Announces the Appointment of Senior Vice President for Commercial Operations.

11th April 2006

Azur Pharma Acquires Gastrocrom®

18th January 2006

Azur Pharma Completes Euro 40 Million Private Placement.

8th June 2005